{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T15:28:01Z","timestamp":1795015681834,"version":"4.10.1"},"reference-count":107,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Low-energy shock wave (LESW) therapy is known to facilitate tissue regeneration with analgesic and anti-inflammatory effects. LESW treatment has been demonstrated to be effective in treating chronic prostatitis and pelvic pain syndrome as well as overactive bladder, and it has a potential effect on interstitial cystitis\/bladder pain syndrome (IC\/BPS) in humans. LESW reduces pain behavior, downregulates nerve growth factor expression, and suppresses bladder overactivity by decreasing the expression of inflammatory proteins. Previous rat IC models have shown that LESW can increase urothelial permeability, facilitate intravesical delivery of botulinum toxin A (BoNT-A), and block acetic acid-induced hyperactive bladder, suggesting that LESW might be a potential therapeutic module for relieving bladder inflammatory conditions, such as bladder oversensitivity, IC\/BPS, and overactive bladder. A recent clinical trial showed that LESW monotherapy was associated with a significant reduction in pain scores and IC symptoms. BoNT-A detrusor injection or liposome-encapsulated BoNT-A instillation could also inhibit inflammation and improve IC symptoms. However, BoNT-A injection requires anesthesia and certain complications might occur. Our preliminary study using LESW plus intravesical BoNT-A instillation every week demonstrated an improvement in global response assessment without any adverse events. Moreover, an immunohistochemistry study revealed the presence of cleaved SNAP25 protein in the suburothelium of IC bladder tissue, indicating that BoNT-A could penetrate across the urothelial barrier after application of LESW. These results provide evidence for the efficacy and safety of this novel IC\/BPS treatment by LESW plus BoNT-A instillation, without anesthesia, and no bladder injection. This article reviews the current evidence on LESW and LESW plus intravesical therapeutic agents on bladder disorders and the pathophysiology and pharmacological mechanism of this novel, minimally invasive treatment model for IC\/BPS.<\/jats:p>","DOI":"10.3390\/biomedicines10020396","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T08:38:48Z","timestamp":1644223128000},"page":"396","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Low-Energy Shock Wave Plus Intravesical Instillation of Botulinum Toxin A for Interstitial Cystitis\/Bladder Pain Syndrome: Pathophysiology and Preliminary Result of a Novel Minimally Invasive Treatment"],"prefix":"10.3390","volume":"10","author":[{"given":"Yuan-Hong","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Buddhist Tzu Chi University, Hualien 97004, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Fong","family":"Jhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Buddhist Tzu Chi University, Hualien 97004, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9325-9868","authenticated-orcid":false,"given":"Yu-Khun","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Buddhist Tzu Chi University, Hualien 97004, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7165-4771","authenticated-orcid":false,"given":"Hann-Chorng","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Buddhist Tzu Chi University, Hualien 97004, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/iju.14234","article-title":"Clinical guidelines for interstitial cystitis\/bladder pain syndrome","volume":"27","author":"Homma","year":"2020","journal-title":"Int. J. Urol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.cellsig.2008.06.004","article-title":"Cell signaling in interstitial cystitis\/painful bladder syndrome","volume":"20","author":"Keay","year":"2008","journal-title":"Cell Signal."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00345-007-0174-7","article-title":"Increased number of apoptotic endothelial cells in bladder of interstitial cystitis patients","volume":"25","author":"Yamada","year":"2007","journal-title":"World J. Urol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"E136","DOI":"10.1111\/j.1464-410X.2010.09911.x","article-title":"Higher levels of cell apoptosis and abnormal E-cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis\/painful bladder syndrome","volume":"108","author":"Shie","year":"2011","journal-title":"BJU Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.eururo.2008.02.037","article-title":"Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity","volume":"53","author":"Apostolidis","year":"2008","journal-title":"Eur. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.urology.2012.01.047","article-title":"Differences in mast cell infiltration, E-cadherin and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis\/bladder pain syndrome","volume":"80","author":"Liu","year":"2012","journal-title":"Urology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1464-410X.2009.08851.x","article-title":"Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis\/bladder pain syndrome and detrusor overactivity","volume":"106","author":"Liu","year":"2010","journal-title":"BJU Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s41598-020-80131-5","article-title":"Urine biomarkers in ESSIC type 2 interstitial cystitis\/bladder pain syndrome and overactive bladder with developing a novel diagnostic algorithm","volume":"11","author":"Jiang","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.urology.2006.03.083","article-title":"Bladder defense molecules, urothelial differentiation, urinary biomarkers, and interstitial cystitis","volume":"69","author":"Hurst","year":"2007","journal-title":"Urology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.urology.2016.08.029","article-title":"Urothelial functional protein and sensory receptors in patients with interstitial cystitis\/bladder pain syndrome with and without Hunner\u2019s lesion","volume":"98","author":"Jhang","year":"2016","journal-title":"Urology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/MI.2005.273","article-title":"Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity","volume":"2005","author":"Arican","year":"2005","journal-title":"Mediat. Inflamm."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.urology.2011.09.049","article-title":"Increased cell apoptosis of the urothelium is mediated by Inflammation in interstitial cystitis\/painful bladder syndrome","volume":"79","author":"Shie","year":"2012","journal-title":"Urology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature09851","article-title":"Hedgehog\/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder","volume":"472","author":"Shin","year":"2011","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.urology.2006.08.1109","article-title":"The mast cell in interstitial cystitis: Role in pathophysiology and pathogenesis","volume":"69","author":"Sant","year":"2007","journal-title":"Urology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/iju.14585","article-title":"Decreased urothelial cytoskeleton and cell proliferation protein expression suggest interstitial cystitis\/bladder pain syndrome patients with Hunner\u2019s lesion and grade 3 glomerulation might be different from other types of patients","volume":"28","author":"Jhang","year":"2021","journal-title":"Int. J. Urol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.5213\/inj.1632712.356","article-title":"Pathomechanism of interstitial cystitis\/bladder pain syndrome and mapping the heterogeneity of disease","volume":"20","author":"Jhang","year":"2016","journal-title":"Int. Neurourol. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"F1391","DOI":"10.1152\/ajprenal.00051.2020","article-title":"Urine cytokines as biomarkers for diagnosing interstitial cystitis\/bladder pain syndrome and mapping its clinical characteristics","volume":"318","author":"Jiang","year":"2020","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0090-4295(01)01166-9","article-title":"Biopsy features are associated with primary symptoms in interstitial cystitis: Results from the interstitial cystitis database study","volume":"57","author":"Tomaszewski","year":"2001","journal-title":"Urology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.urology.2011.05.050","article-title":"Increased expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor associated with glomerulation formation in patients with interstitial cystitis","volume":"78","author":"Lee","year":"2011","journal-title":"Urology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.cca.2012.06.012","article-title":"Urinary biomarkers of oxidative status","volume":"413","author":"Scarbrough","year":"2012","journal-title":"Clin. Chim. Acta."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0891-5849(99)00264-6","article-title":"Measurement of F (2)-isoprostanes as an index of oxidative stress in vivo","volume":"28","author":"Roberts","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5213\/inj.2040104.052","article-title":"New frontiers or the treatment of interstitial cystitis\/bladder pain syndrome\u2014Focused on stem cells, platelet-rich plasma, and low-energy shock wave","volume":"24","author":"Lin","year":"2020","journal-title":"Int. Neurourol. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.bbagen.2013.06.030","article-title":"In vitro measurements and interpretation of total antioxidant capacity","volume":"1840","author":"Fraga","year":"2014","journal-title":"Biochim. Biophys. Acta."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.juro.2014.03.037","article-title":"Partial bladder outlet obstruction in mice may cause E-cadherin repression through hypoxia induced pathway","volume":"192","author":"Iguchi","year":"2014","journal-title":"J. Urol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Fusco, F., Creta, M., De Nunzio, C., Iacovelli, V., Mangiapia, F., Marzi, V.L., and Agro, E.F. (2018). Progressive bladder remodeling due to bladder outlet obstruction: A systematic review of morphological and molecular evidences in humans. BMC Urol., 18.","DOI":"10.1186\/s12894-018-0329-4"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Miyata, Y., Matsuo, T., Mitsunari, K., Asai, A., Ohba, K., and Sakai, H. (2019). A review of oxidative stress and urinary dysfunction caused by bladder outlet obstruction and treatments using antioxidants. Antioxidants, 8.","DOI":"10.3390\/antiox8050132"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s11934-006-0051-8","article-title":"Dysfunction of bladder urothelium and bladder urothelial cells in interstitial cystitis","volume":"7","author":"Graham","year":"2006","journal-title":"Curr. Urol. Rep."},{"key":"ref_28","first-page":"638","article-title":"Interstitial cystitis\/bladder pain syndrome and glycosaminoglycans replacement therapy","volume":"4","author":"Cervigni","year":"2015","journal-title":"Transl. Androl. Urol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/01.ju.0000099660.46774.3c","article-title":"Up-regulation of P2X3 receptor during stretch of bladder urothelial cells from patients with interstitial cystitis","volume":"171","author":"Sun","year":"2004","journal-title":"J. Urol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.urology.2009.02.066","article-title":"Changes in adenosine triphosphate-stimulated ATP release suggest association between cytokine and purinergic signaling in bladder urothelial cells","volume":"74","author":"Sun","year":"2009","journal-title":"Urology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1464-410X.1989.tb05188.x","article-title":"Scanning electron microscopic findings in interstitial cystitis","volume":"63","author":"Fall","year":"1989","journal-title":"Br. J. Urol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0022-5347(01)67669-9","article-title":"Activation of bladder mast cells in interstitial cystitis: A light and electron microscopic study","volume":"153","author":"Theoharides","year":"1995","journal-title":"J. Urol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Jhang, J.F., Ho, H.C., Jiang, Y.H., Lee, C.L., Hsu, Y.H., and Kuo, H.C. (2018). Electron microscopic characteristics of interstitial cystitis\/bladder pain syndrome and their association with clinical condition. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0198816"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.juro.2007.05.125","article-title":"Uroplakin III-delta4 messenger RNA as a promising marker to identify nonulcerative interstitial cystitis","volume":"178","author":"Zeng","year":"2007","journal-title":"J. Urol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/aja.1001500203","article-title":"A study by scanning electron microscopy of the bladder epithelium of the guinea pig","volume":"150","author":"Wong","year":"1977","journal-title":"Am. J. Anat."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"17258","DOI":"10.1038\/s41598-021-96810-w","article-title":"Difference in electron microscopic findings among interstitial cystitis\/bladder pain syndrome with distinct clinical and cystoscopic characteristics","volume":"11","author":"Lee","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/mds.20003","article-title":"Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin","volume":"19","author":"Erbguth","year":"2004","journal-title":"Mov. Disord."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"23479","DOI":"10.1016\/S0021-9258(18)35863-0","article-title":"Botulinum neurotoxins are zink proteins","volume":"267","author":"Schiavo","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev.pa.26.040186.002235","article-title":"Molecular pharmacology of botulinum toxin and tetanus toxoid","volume":"26","author":"Simpson","year":"1986","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.neuint.2007.11.006","article-title":"Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury","volume":"52","author":"Smith","year":"2008","journal-title":"Neurochem. Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1464-410X.2007.07312.x","article-title":"Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute and chronic inflammation","volume":"101","author":"Lucioni","year":"2008","journal-title":"BJU Int."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1046\/j.1464-410x.2001.02190.x","article-title":"Capsaicin receptor VR1 and ATP-gated ion channel P2X3 in human urinary bladder","volume":"87","author":"Yiangou","year":"2001","journal-title":"BJU Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.coph.2011.11.001","article-title":"Neurotherapeutics to inhibit exocytosis from sensory neurons for the control of chronic pain","volume":"12","author":"Dolly","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.toxicon.2013.05.011","article-title":"A closer look to botulinum neurotoxin type A-induced analgesia","volume":"71","author":"Guo","year":"2013","journal-title":"Toxicon"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1464-410X.2009.08495.x","article-title":"Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis\/painful bladder syndrome","volume":"104","author":"Kuo","year":"2009","journal-title":"BJU Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.juro.2013.05.049","article-title":"Increased mRNA expression of genes involved in pronociceptive inflammatory reactions in bladder tissue of interstitial cystitis","volume":"190","author":"Homma","year":"2013","journal-title":"J. Urol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1152\/jn.2000.84.4.1924","article-title":"Sensory fibers of the pelvic nerve innervating the rat\u2019s urinary bladder","volume":"84","author":"Shea","year":"2000","journal-title":"J. Neurophysiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000087173","article-title":"Preliminary results of suburothelial injection of botulinum A toxin in the treatment of chronic interstitial cystitis","volume":"75","author":"Kuo","year":"2005","journal-title":"Urol. Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.eururo.2005.12.002","article-title":"Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: A pilot study","volume":"49","author":"Giannantoni","year":"2006","journal-title":"Eur. Urol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1479-666X(07)80084-9","article-title":"Intravesical botulinum toxin type A in chronic interstitial cystitis: Results of a pilot study","volume":"5","author":"Ramsay","year":"2007","journal-title":"Surgeon"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2174\/156720110793566317","article-title":"Botulinum a toxin intravesical injections for painful bladder syndrome: Impact upon pain, psychological functioning and quality of life","volume":"7","author":"Giannantoni","year":"2010","journal-title":"Curr. Drug Deliv."},{"key":"ref_53","first-page":"197","article-title":"Intravesical onabotulinumtoxin: A injections for refractory painful bladder syndrome","volume":"15","author":"Chung","year":"2012","journal-title":"Pain Physician"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.36076\/ppj.2013\/16\/E15","article-title":"Repeated onabotulinumtoxin-A Injections provide better results than single injection in treatment of painful bladder syndrome","volume":"16","author":"Kuo","year":"2013","journal-title":"Pain Physician"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.juro.2015.01.087","article-title":"Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline amendment","volume":"193","author":"Gormley","year":"2015","journal-title":"J. Urol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.eururo.2017.12.031","article-title":"EAU Guidelines on Assessment and Nonsurgical Management of Urinary Incontinence","volume":"73","author":"Nambiar","year":"2018","journal-title":"Eur. Urol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/nau.22760","article-title":"Intravesical botulinum toxin\u2014A injections reduce bladder pain of interstitial cystitis\/bladder pain syndrome refractory to conventional treatment\u2014A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial","volume":"35","author":"Kuo","year":"2016","journal-title":"Neurourol. Urodyn."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.juro.2015.01.086","article-title":"Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome: AUA guideline amendment","volume":"193","author":"Hanno","year":"2015","journal-title":"J. Urol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/iju.13118","article-title":"Clinical guidelines for interstitial cystitis and hypersensitive bladder updated in 2015","volume":"23","author":"Homma","year":"2016","journal-title":"Int. J. Urol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.eururo.2014.01.036","article-title":"Pilot study of liposome-encapsulated onabotulinumtoxina for patients with overactive bladder: A single-center study","volume":"65","author":"Kuo","year":"2014","journal-title":"Eur. Urol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"601653","DOI":"10.1155\/2014\/601653","article-title":"Intravesical liposome and antisense 809 treatment for detrusor overactivity and interstitial cystitis\/painful bladder syndrome","volume":"2014","author":"Tyagi","year":"2014","journal-title":"ISRN Pharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Liu, H.T., Chen, S.H., Chancellor, M.B., and Kuo, H.C. (2015). Presence of cleaved snaptosomal-Aassociated protein-25 and decrease of purinergic receptors P2X3 in the bladder urothelium influence efficacy of botulinum toxin treatment for overactive bladder syndrome. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0134803"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.juro.2014.07.008","article-title":"Bladder instillation of liposome encapsulated onabotulinumtoxina improves overactive bladder symptoms: A prospective, multicenter, double-blind, randomized trial","volume":"192","author":"Chuang","year":"2014","journal-title":"J. Urol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.juro.2017.02.021","article-title":"A prospective, multicenter, double-blind, randomized trial of bladder instillation of liposome formulation onabotulinumtoxinA for interstitial cystitis\/bladder pain syndrome","volume":"198","author":"Chuang","year":"2017","journal-title":"J. Urol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/09537104.2016.1143922","article-title":"Cytokine, chemokine, and growth factor profile of platelet-rich plasma","volume":"27","author":"Mussano","year":"2016","journal-title":"Platelets"},{"key":"ref_66","first-page":"O42","article-title":"Repeated intravesical injections of platelet-rich plasma are effective in the treatment of interstitial cystitis: A case control pilot study","volume":"11","author":"Jhang","year":"2019","journal-title":"Low. Urin. Tract Symptoms"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/nau.23898","article-title":"Intravesical injections of platelet-rich plasma is effective and safe in treatment of interstitial cystitis refractory to conventional treatment-A prospective clinical trial","volume":"38","author":"Jhang","year":"2019","journal-title":"Neurourol. Urodyn."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"15218","DOI":"10.1038\/s41598-020-72292-0","article-title":"Repeated intravesical injections of platelet-rich plasma improve symptoms and alter urinary functional proteins in patients with refractory interstitial cystitis","volume":"10","author":"Jiang","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_69","first-page":"135","article-title":"Therapeutic potential of intravesical injections of platelet-rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiency","volume":"31","author":"Ke","year":"2019","journal-title":"Ci. Ji. Yi. Xue. Za. Zhi."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/luts.12364","article-title":"Urothelial health after platelet-rich plasma injection in intractable recurrent urinary tract infection: Improved cell proliferation, cytoskeleton, and barrier function protein expression","volume":"13","author":"Jiang","year":"2021","journal-title":"Low. Urin. Tract Symptoms"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1469-185X.1975.tb01057.x","article-title":"The mammalian urinary bladder: An accommodating organ","volume":"50","author":"Hicks","year":"1975","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"8105","DOI":"10.1073\/pnas.1221216110","article-title":"p63-expressing cells are the stem cells of developing prostate, bladder, and colorectal epithelia","volume":"110","author":"Pignon","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Jhang, J.F., Jiang, Y.H., Hsu, Y.H., Ho, H.C., Birder, L.A., Lin, T.Y., and Kuo, H.C. (2022). Improved urothelial cell proliferation, cytoskeleton and barrier function protein expression in the patients with interstitial cystitis\/bladder pain syndrome after intravesical platelet-rich plasma injection. Int. Neurourol. J.","DOI":"10.5213\/inj.2221050.corrigendum"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/14764172.2017.1334928","article-title":"Extracorporeal shockwave: Mechanisms of action and physiological aspects for cellulite, body shaping, and localized fat\u2014Systematic review","volume":"19","author":"Modena","year":"2017","journal-title":"J. Cosmet. Laser Ther."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41443-019-0113-3","article-title":"Cellular signaling pathways modulated by low-intensity extracorporeal shock wave therapy","volume":"31","author":"Liu","year":"2019","journal-title":"Int. J. Impot. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.2174\/092986709788682119","article-title":"Extracorporeal shock wave therapy in inflammatory diseases: Molecular mechanism that triggers anti-inflammatory action","volume":"16","author":"Mariotto","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/nau.23141","article-title":"Effects of low energy shock wave therapy on inflammatory moleculars, bladder pain, and bladder function in a rat cystitis model","volume":"36","author":"Wang","year":"2017","journal-title":"Neurourol. Urodyn."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/bju.14216","article-title":"Low-intensity extracorporeal shockwave therapy ameliorates diabetic underactive bladder in streptozotocin-induced diabetic rats","volume":"122","author":"Wang","year":"2018","journal-title":"BJU Int."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.7150\/ijms.55274","article-title":"Therapeutic effect of Low intensity Extracorporeal Shock Wave Therapy (Li-ESWT) on diabetic bladder dysfunction in a rat model","volume":"18","author":"Lee","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s11255-019-02095-4","article-title":"Long-term functional change of cryoinjury-induced detrusor underactivity and effects of extracorporeal shock wave therapy in a rat model","volume":"51","author":"Chuang","year":"2019","journal-title":"Int. Urol. Nephrol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Wang, H.J., Tyagi, P., Lin, T.K., Huang, C.C., Lee, W.C., Chancellor, M.B., and Chuang, Y.C. (2021). Low energy shock wave therapy attenuates mitochondrial dysfunction and improves bladder function in HCl induced cystitis in rats. Biomed. J.","DOI":"10.1016\/j.bj.2021.06.006"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4111\/icu.2019.60.5.359","article-title":"Treatment with low-energy shock wave alleviates pain in an animal model of uroplakin 3A-induced autoimmune interstitial cystitis\/painful bladder syndrome","volume":"60","author":"Li","year":"2019","journal-title":"Investig. Clin. Urol."},{"key":"ref_83","first-page":"e14260","article-title":"Efficacy and safety evaluation of low-intensity extracorporeal shock wave therapy on prostatitis-like symptoms: An open-label, single-arm trial","volume":"28","author":"Jin","year":"2021","journal-title":"Andrologia"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Lu, J.H., Chueh, K.S., Chuan, G.S.M., Wu, Y.H., Lin, K.L., Long, C.Y., Lee, Y.C., She, N.M.C., Sun, T.W., and Juan, Y.S. (2021). Low intensity extracorporeal shock wave therapy as a potential treatment for overactive bladder syndrome. Biology, 10.","DOI":"10.3390\/biology10060540"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Chen, P.Y., Lee, W.C., Wang, H.J., and Chuang, Y.C. (2020). Therapeutic efficacy of onabotulinumtoxin: A delivered using various approaches in sensory bladder disorder. Toxins, 12.","DOI":"10.3390\/toxins12020075"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/bju.15173","article-title":"Effect of low-energy shock wave therapy on intravesical epirubicin delivery in a rat model of bladder cancer","volume":"127","author":"Elkashef","year":"2021","journal-title":"BJU Int."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.plrev.2018.06.018","article-title":"An overview of a novel use of shockwaves to alter cell permeability: Comment on \u201cShock wave-induced permeabilization of mammalian cells\u201d by Luz M. Lopez-Marin et al","volume":"26\u201327","author":"Datey","year":"2018","journal-title":"Phys. Life Rev."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/bit.26016","article-title":"A miniature shock wave driven micro-jet injector for needle-free vaccine\/drug delivery","volume":"113","author":"Battula","year":"2016","journal-title":"Biotechnol. Bioeng."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ultrasmedbio.2017.09.010","article-title":"Effects of extracorporeal shock wave-mediated transdermal local anesthetic drug dselivery on rat caudal nerves","volume":"44","author":"Luh","year":"2018","journal-title":"Ultrasound. Med. Biol."},{"key":"ref_90","first-page":"1036","article-title":"Extracorporeal shock wave markedly alleviates radiation-induced chronic cystitis in rat","volume":"10","author":"Chen","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1749-799X-7-11","article-title":"Extracorporeal shockwave therapy in musculoskeletal disorders","volume":"7","author":"Wang","year":"2012","journal-title":"J. Orthop. Surg. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"675","DOI":"10.5535\/arm.2012.36.5.675","article-title":"Extracorporeal shock wave therapy in myofascial pain syndrome of upper trapezius","volume":"36","author":"Ji","year":"2012","journal-title":"Ann. Rehabil. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"27090","DOI":"10.1074\/jbc.M114.580936","article-title":"Shock wave treatment enhances cell proliferation and improves wound healing by ATP release-coupled extracellular signal-regulated kinase (ERK) activation","volume":"289","author":"Weih","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0304-3940(01)02320-5","article-title":"Shock wave application to rat skin induces degeneration and reinnervation of sensory nerve fibres","volume":"315","author":"Ohtori","year":"2001","journal-title":"Neurosci. Lett."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/nau.24382","article-title":"Pain reduction realized with extracorporeal shock wave therapy for the treatment of symptoms associated with interstitial cystitis\/bladder pain syndrome-A prospective, multicenter, randomized, double-blind, placebo-controlled study","volume":"39","author":"Chuang","year":"2020","journal-title":"Neurourol. Urodyn."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.juro.2015.12.078","article-title":"Urodynamic and immunohistochemical evaluation of intravesical botulinum toxin: A delivery using low energy shock waves","volume":"196","author":"Chuang","year":"2016","journal-title":"J. Urol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/nau.24511","article-title":"Low energy shock wave-delivered intravesical botulinum neurotoxin-A potentiates antioxidant genes and inhibits proinflammatory cytokines in rat model of overactive bladder","volume":"39","author":"Nageib","year":"2020","journal-title":"Neurourol. Urodyn."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/JU.0000000000001334","article-title":"Clinical relevance of bladder histopathological findings and their impact on treatment outcomes among patients with iterstitial cystitis\/bladder pain syndrome: An investigation of the European Society for the study of interstitial cystitis histopathological classification","volume":"205","author":"Jhang","year":"2021","journal-title":"J. Urol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41598-020-80252-x","article-title":"Cystoscopic hydrodistention characteristics provide clinical and long-term prognostic features of interstitial cystitis after treatment","volume":"11","author":"Yu","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.juro.2018.03.133","article-title":"Epstein\u2013barr virus presence as a potential etiology of persistent ladder inflammation in human iterstitial ystitis\/bladder pain syndrome","volume":"200","author":"Jhang","year":"2018","journal-title":"J. Urol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.juro.2006.09.029","article-title":"Changes in urine markers and symptoms after bladder distention for interstitial cystitis","volume":"177","author":"Erickson","year":"2007","journal-title":"J. Urol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1159\/000447863","article-title":"Systematic review and mta-Aanalysis of intravesical hyaluronic acid and hyaluronic acid\/chondroitin sulfate instillation for interstitial cystitis\/painful bladder syndrome","volume":"39","author":"Pyo","year":"2016","journal-title":"Cell Physiol. Biochem."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Jhang, J.F. (2019). Using botulinum toxin A for treatment of interstitial cystitis\/bladder pain syndrome-possible pathomechanisms and practical issues. Toxins, 11.","DOI":"10.3390\/toxins11110641"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jpsychores.2014.10.003","article-title":"Bladder pain syndrome\/interstitial cystitis as a functional somatic syndrome","volume":"77","author":"Warren","year":"2014","journal-title":"J. Psychosom. Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.juro.2014.07.108","article-title":"International Interstitial Cystitis Study Group. Clinical and psychological parameters associated with pain pattern phenotypes in women with interstitial cystitis\/bladder pain syndrome","volume":"193","author":"Nickel","year":"2015","journal-title":"J. Urol."},{"key":"ref_106","first-page":"611","article-title":"A multidisciplinary approach to the evaluation and management of interstitial cystitis\/bladder pain syndrome: An ideal model of care","volume":"4","author":"Gupta","year":"2015","journal-title":"Transl. Androl. Urol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/1756287218761574","article-title":"Current best practice management of interstitial cystitis\/bladder pain syndrome","volume":"10","author":"Han","year":"2018","journal-title":"Ther. Adv. Urol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/2\/396\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:15:27Z","timestamp":1760134527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/2\/396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,7]]},"references-count":107,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["biomedicines10020396"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10020396","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,7]]}}}